Hybrid FlexyRap - Drug Eluting Coronary Stent - SLTL Medical

* Sahajanand Laser Technology Ltd. reserves the right to make changes at any time without prior notice or notification ** The price is not final; please consult with the SLTL team for the final price. Cobalt Chromium Rapamycin-Eluting Coronary Stent System (From Biodegradable Polymer Matrix) FlexyRap has a coating which undergoes complete biodegradation of polymer within 7 to 9 months FlexyRap has drug /polymer coating of a 5-6 micron which gives excellent deliverability to follow vessel motion which ensures conformability. The growth of 8% from Nominal pressure to RBP allows complete development and good wall apposition. Flexyrap is a Biodegradable polymer with biocompatibility. Engineered with unparallel flexibility with the pivoted articulation design it ensures good trackability, crossability & conformability. Key Features Biodegradable Polymer with excellent biocompatibility Sustained Rapamycin (Sirolimus) release over 28 days for therapeutic efficacy. Semi Open (Hybrid) U.S. Patented Stent Design. Drug : Rapamycin (Sirolimus) Dose: 1μg/mm² Superior Stent mechanics through strong cobalt chromium alloy. Better fatigue and corrosion resistance performance. Coating thickness less than 6μ Growth of 8% from nominal pressure to RBP allowing complete deployment and good wall apposition. Ultra-smooth Electropolished finishing. * Final price depends on required configurations. About the Company Legal Status of Firm: Limited Company Number of Employees: 1001 To 2000 People Annual Turnover: 100 - 500 Cr company-description: Innovation is at the foundation of this organization, as just after its establishment, SLTL invented a fiber laser cutting machine which became a game-changer for the metal-forming industry.The SLTL Group is a global technological conglomerate headquartered in Gandhinagar, Gujarat, India which was established in the year 1989 under the leadership of Dr Arvind Patel. Today, the Group operates in six verticals covering industries like Industrial laser, Gems and Jewellery, Medical Devices & Equipment, RF & Microwave, Renewable energy and Hi-tech software.With more than 25,000 successful installations and a global footprint in over 48+ countries. In a mere span of 36 years, the team has been felicitated with 38+ awards and registered 31+ patents for their innovative solutions. The Indian subcontinent, South East Asia, the Middle East, Russia, China, Europe, the USA, Canada, and Latin America have become SLTL's exporting hub for laser undertakings. With the team's efforts and in-house R&D centre, SLTL Group has registered 26+ patents in its name. SLTL Group's core engineering department was specifically formed to address complex needs. For years, it has successfully introduced groundbreaking products and advancements that led to boosting the productivity of industries across the globe. We've got the vision to deliver continuous innovation, working in the future.